Second-line FOLFOX is not the standard of care for all patients with advanced biliary tract cancer-a commentary from the Young International Society of Geriatric Oncology

Affiliations

¹ Department of Oncology, Odense University Hospital, Odense, Denmark; Department of Clinical Research, University of Southern Denmark, Odense, Denmark; Academy of Geriatric Cancer Research (AgeCare), Odense, Denmark. Electronic address: gabor.istvan.liposits@rsyd.dk.
² Division of Hematology/Oncology, Mays Cancer Center, University of Texas Health San Antonio, San Antonio, USA. Electronic address: https://twitter.com/DrSukeshiArora.
³ Department of Medicine, The Royal Marsden NHS Foundation Trust, Sutton, UK; Breast Cancer Research Division, The Institute of Cancer Research, Sutton, London, UK. Electronic address: https://twitter.com/nicolobattisti.
⁴ Department of Geriatrics, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico. Electronic address: https://twitter.com/EnriqueSoto8.
⁵ Division of Hematology/Oncology, Department of Medicine, James P. Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, USA. Electronic address: https://twitter.com/MelissaLoh21.
⁶ Division of Hematology/Oncology, University of Alabama at Birmingham, Birmingham, USA. Electronic address: https://twitter.com/GrantWilliamsMD.

Free article

Comment

G Liposits et al. Ann Oncol. 2023 Jun.

Free article

. 2023 Jun;34(6):555-556.

doi: 10.1016/j.annonc.2023.02.007. Epub 2023 Feb 21.

¹ Department of Oncology, Odense University Hospital, Odense, Denmark; Department of Clinical Research, University of Southern Denmark, Odense, Denmark; Academy of Geriatric Cancer Research (AgeCare), Odense, Denmark. Electronic address: gabor.istvan.liposits@rsyd.dk.
² Division of Hematology/Oncology, Mays Cancer Center, University of Texas Health San Antonio, San Antonio, USA. Electronic address: https://twitter.com/DrSukeshiArora.
³ Department of Medicine, The Royal Marsden NHS Foundation Trust, Sutton, UK; Breast Cancer Research Division, The Institute of Cancer Research, Sutton, London, UK. Electronic address: https://twitter.com/nicolobattisti.
⁴ Department of Geriatrics, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico. Electronic address: https://twitter.com/EnriqueSoto8.
⁵ Division of Hematology/Oncology, Department of Medicine, James P. Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, USA. Electronic address: https://twitter.com/MelissaLoh21.
⁶ Division of Hematology/Oncology, University of Alabama at Birmingham, Birmingham, USA. Electronic address: https://twitter.com/GrantWilliamsMD.

No abstract available

Conflict of interest statement

Disclosure The authors have declared no conflicts of interest.

Biliary tract cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.
Vogel A, Bridgewater J, Edeline J, Kelley RK, Klümpen HJ, Malka D, Primrose JN, Rimassa L, Stenzinger A, Valle JW, Ducreux M; ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org. Vogel A, et al. Ann Oncol. 2023 Feb;34(2):127-140. doi: 10.1016/j.annonc.2022.10.506. Epub 2022 Nov 10. Ann Oncol. 2023. PMID: 36372281 No abstract available.